Implementation of a Pediatric Oncology Precision Medicine Clinic to Personalize Approaches for Diagnosing and Treating Solid Tumors
While the PMC continues to evaluate patients and their long-term outcomes, the continually growing PMC at CCMC represents the beginning of the advancement of treating pediatric oncology patients through the interpretation of genetic sequencing results, making actionable targeted treatment recommendations, and continuing to follow the patient's course of care over time. This additionally provides a framework for starting a PMC that can be adapted for specific clinical needs and implemented broadly.
Authors
- Madeline Keane
- Natalia Wojciechowska (ORCID: https://orcid.org/0000-0003-1727-748X)
- Anish Ray (ORCID: https://orcid.org/0000-0002-6349-1869)
- Jason Wang
- Alejandra Domínguez (ORCID: https://orcid.org/0000-0002-0953-176X)
- Lindsay Zumwalt
- Emilie K. Sandfeld
Institutions
- Texas A&M University (US)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/or.2025.065547
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00